fanasil, pyrimethamine drug combination has been researched along with Lymphoma, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukutomi, Y; Goto, H; Hara, T; Moriwaki, H; Murakami, N; Tajika, M; Tsurumi, H; Yoshimura, K | 1 |
1 other study(ies) available for fanasil, pyrimethamine drug combination and Lymphoma, T-Cell
Article | Year |
---|---|
[Non-Hodgkin's lymphoma with Toxoplasma encephalitis].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Combinations; Encephalitis; Humans; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Pyrimethamine; Remission Induction; Sulfadoxine; Toxoplasmosis, Cerebral; Vincristine | 1999 |